| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $200K | — | +177.8% |
| SG&A Expense | $381K | — | +155.7% |
| Operating Income | -$581K | — | -162.9% |
| Interest Expense | $54K | — | +2800.0% |
| Income Tax | -$35K | — | — |
| Net Income | -$540K | — | -130.8% |
| EPS (Diluted) | -$0.05 | — | -150.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $252K | +27.9% | +663.6% |
| Current Assets | $277K | +8.6% | -28.8% |
| Total Assets | $8.9M | -1.5% | +1838.5% |
| Current Liabilities | $2.7M | +19.6% | +183.1% |
| Total Liabilities | $4.3M | +10.5% | +335.9% |
| Stockholders' Equity | $1.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$333K | — | -68.2% |
| Financing Cash Flow | $300K | — | +1.7% |
| +301.7% |